June 24, 2022
NOT-OD-22-100 - iEdison to Transition from NIH eRA to NIST in Summer 2022; Action Required by Users
NOT-OD-15-004 - Reminder Notice Regarding Requirements of the Bayh-Dole Act and the NIH’s Implementing Regulations
NOT-OD-15-080 - Notice Regarding Requirement of Grantees and Contractors to Submit Invention Disclosures, Related Reports and Documents Via iEdison
NATIONAL INSTITUTES OF HEALTH (NIH)
To inform iEdison system users that the iEdison system will be unavailable from August 2-8, 2022 in preparation for the transition from NIH eRA to the National Institute of Standards and Technology (NIST), U.S. Department of Commerce (DOC) and the proposed launch of the new iEdison by NIST on August 9. In addition, remind iEdison system users of long-standing compliance requirements regarding invention reporting and the consequences for noncompliance.
As was outlined in NOT-OD-22-100, the management of iEdison, the system used by awardees to report inventions and patents resulting from federal research funding per the Bayh-Dole Act (35 U.S.C. 200-206), is transitioning from the NIH eRA to the DOC NIST iEdison was developed and has been managed by NIH since 1995.
Reminder: Actions for Users to Take Before the Transition
To ensure a smooth transition, iEdison users should:
Additional information on these training opportunities will be posted on www.nist.gov/iedison and sent to those who have subscribed to NIST updates.
Reminders about Complying With NIH Invention Reporting Policies
Please note that there will be no changes to the longstanding NIH requirements for invention and patent reporting under the Bayh-Dole Act, as incorporated by reference as a term and condition of every NIH grant award. The only change will be the new iEdison system interface and associated Login.gov requirements for access. Please see the NIH Grants Policy Statement (NIHGPS) sections below for the specific invention reporting requirements and associated summary table, the recipient’s agreement to comply with all terms and conditions of the award via drawing funds from the HHS payment system, and the enforcement mechanisms for non-compliance with terms of the award.
Please be mindful of the important dates above and submit your compliance documents early to ensure compliance for any required submissions due during the period of shutdown.
Important Note: Failure of the NIH recipient to comply with any of the Bayh-Dole regulations cited at 37 CFR Part 401 or other requirements may result in the loss of patent rights or the suspension, termination, or withholding of NIH funding support.